Free tool
FAERS Monitor: Kyleena
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208224 or its brand name (Kyleena, Levonorgestrel). Reports on generic versions are filed under their own applications.
Reports
11,993
Serious
5,950
50% of reports
Hospitalization
1,128
Death reported
66
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- device expulsion2,145
- device dislocation1,616
- drug ineffective1,128
- genital haemorrhage824
- complication of device insertion674
- abdominal pain lower662
- pregnancy with contraceptive device487
- procedural pain426
- ectopic pregnancy with contraceptive device384
- nausea337
- vaginal haemorrhage330
- headache295
- abdominal pain290
- pelvic pain288
- fatigue245
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 39 |
| 2005 | 39 |
| 2006 | 37 |
| 2007 | 27 |
| 2008 | 22 |
| 2009 | 45 |
| 2010 | 64 |
| 2011 | 93 |
| 2012 | 101 |
| 2013 | 45 |
| 2014 | 33 |
| 2015 | 72 |
| 2016 | 119 |
| 2017 | 395 |
| 2018 | 934 |
| 2019 | 1,206 |
| 2020 | 1,548 |
| 2021 | 1,375 |
| 2022 | 1,391 |
| 2023 | 1,411 |
| 2024 | 1,168 |
| 2025 | 1,041 |
| 2026 | 788 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,166 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| ectopic pregnancy with contraceptive deviceSignal | 384 | 510.0 | 455.9 | 150,764 |
| genital haemorrhageSignal | 824 | 120.0 | 112.1 | 90,935 |
| pregnancy with contraceptive deviceSignal | 487 | 100.8 | 92.1 | 45,420 |
| device dislocationSignal | 1,616 | 67.7 | 64.6 | 102,336 |
| complication of device insertionSignal | 674 | 61.5 | 57.0 | 38,705 |
| device expulsionSignal | 2,145 | 60.0 | 57.7 | 120,555 |
| abdominal pain lowerSignal | 662 | 47.1 | 43.7 | 29,100 |
| pelvic painSignal | 288 | 28.2 | 25.2 | 7,424 |
| procedural painSignal | 426 | 27.3 | 24.9 | 10,632 |
| vaginal haemorrhageSignal | 330 | 13.4 | 12.1 | 3,762 |
| abdominal painSignal | 290 | 2.2 | 2.0 | 188 |
| drug ineffective | 1,128 | 1.5 | 1.4 | 201 |
| headache | 295 | 0.8 | 0.7 | 11 |
| nausea | 337 | 0.7 | 0.7 | 30 |
| fatigue | 245 | 0.6 | 0.5 | 92 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.